In this report, the United States Statins market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Statins in these regions, from 2013 to 2025 (forecast). United States Statins market competition by top manufacturers/players, with Statins sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Pfizer Merck Teva Amgen Abbott AstraZeneca Novartis SUN Pharma Torrent Pharmaceuticals GlaxoSmithKline HanAll BioPharma... Research Beam Model: Research Beam Product ID: 2921774 3800 USD New
United States Statins Market Report 2018
 
 

United States Statins Market Report 2018

  • Category : Pharmaceuticals
  • Published On : February   2018
  • Pages : 114
  • Publisher : QYResearch
 
 
 
In this report, the United States Statins market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Statins in these regions, from 2013 to 2025 (forecast).

United States Statins market competition by top manufacturers/players, with Statins sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Merck
Teva
Amgen
Abbott
AstraZeneca
Novartis
SUN Pharma
Torrent Pharmaceuticals
GlaxoSmithKline
HanAll BioPharma
JX Pharmaceuticals
Aurobindo Pharma
Abbvie
Cerenis Therapeutics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Atorvastatin (Lipitor)
Fluvastatin (Lescol)
Lovastatin
Pitavastatin (Livalo)
Pravastatin (Pravachol)
Rosuvastatin (Crestor)
Simvastatin (Zocor)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Statins Market Report 2018
1 Statins Overview
1.1 Product Overview and Scope of Statins
1.2 Classification of Statins by Product Category
1.2.1 United States Statins Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Statins Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Atorvastatin (Lipitor)
1.2.4 Fluvastatin (Lescol)
1.2.5 Lovastatin
1.2.6 Pitavastatin (Livalo)
1.2.7 Pravastatin (Pravachol)
1.2.8 Rosuvastatin (Crestor)
1.2.9 Simvastatin (Zocor)
1.3 United States Statins Market by Application/End Users
1.3.1 United States Statins Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 United States Statins Market by Region
1.4.1 United States Statins Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Statins Status and Prospect (2013-2025)
1.4.3 Southwest Statins Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Statins Status and Prospect (2013-2025)
1.4.5 New England Statins Status and Prospect (2013-2025)
1.4.6 The South Statins Status and Prospect (2013-2025)
1.4.7 The Midwest Statins Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Statins (2013-2025)
1.5.1 United States Statins Sales and Growth Rate (2013-2025)
1.5.2 United States Statins Revenue and Growth Rate (2013-2025)

2 United States Statins Market Competition by Players/Suppliers
2.1 United States Statins Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Statins Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Statins Average Price by Players/Suppliers (2013-2018)
2.4 United States Statins Market Competitive Situation and Trends
2.4.1 United States Statins Market Concentration Rate
2.4.2 United States Statins Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Statins Manufacturing Base Distribution, Sales Area, Product Type

3 United States Statins Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Statins Sales and Market Share by Region (2013-2018)
3.2 United States Statins Revenue and Market Share by Region (2013-2018)
3.3 United States Statins Price by Region (2013-2018)

4 United States Statins Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Statins Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Statins Revenue and Market Share by Type (2013-2018)
4.3 United States Statins Price by Type (2013-2018)
4.4 United States Statins Sales Growth Rate by Type (2013-2018)

5 United States Statins Sales (Volume) by Application (2013-2018)
5.1 United States Statins Sales and Market Share by Application (2013-2018)
5.2 United States Statins Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 United States Statins Players/Suppliers Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Statins Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Statins Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Merck
6.2.2 Statins Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Merck Statins Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Teva
6.3.2 Statins Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Teva Statins Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Amgen
6.4.2 Statins Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Amgen Statins Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Abbott
6.5.2 Statins Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Abbott Statins Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 AstraZeneca
6.6.2 Statins Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 AstraZeneca Statins Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Novartis
6.7.2 Statins Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novartis Statins Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 SUN Pharma
6.8.2 Statins Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 SUN Pharma Statins Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Torrent Pharmaceuticals
6.9.2 Statins Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Torrent Pharmaceuticals Statins Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 GlaxoSmithKline
6.10.2 Statins Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 GlaxoSmithKline Statins Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 HanAll BioPharma
6.12 JX Pharmaceuticals
6.13 Aurobindo Pharma
6.14 Abbvie
6.15 Cerenis Therapeutics

7 Statins Manufacturing Cost Analysis
7.1 Statins Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Statins

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Statins Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Statins Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Statins Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Statins Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Statins Sales Volume Forecast by Type (2018-2025)
11.3 United States Statins Sales Volume Forecast by Application (2018-2025)
11.4 United States Statins Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Statins
Figure United States Statins Market Size (K Units) by Type (2013-2025)
Figure United States Statins Sales Volume Market Share by Type (Product Category) in 2017
Figure Atorvastatin (Lipitor) Product Picture
Figure Fluvastatin (Lescol) Product Picture
Figure Lovastatin Product Picture
Figure Pitavastatin (Livalo) Product Picture
Figure Pravastatin (Pravachol) Product Picture
Figure Rosuvastatin (Crestor) Product Picture
Figure Simvastatin (Zocor) Product Picture
Figure United States Statins Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Statins by Application in 2017
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure United States Statins Market Size (Million USD) by Region (2013-2025)
Figure The West Statins Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Statins Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Statins Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Statins Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Statins Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Statins Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Statins Sales (K Units) and Growth Rate (2013-2025)
Figure United States Statins Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Statins Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Statins Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Statins Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Statins Sales Share by Players/Suppliers
Figure 2017 United States Statins Sales Share by Players/Suppliers
Figure United States Statins Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Statins Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Statins Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Statins Revenue Share by Players/Suppliers
Figure 2017 United States Statins Revenue Share by Players/Suppliers
Table United States Market Statins Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Statins Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Statins Market Share of Top 3 Players/Suppliers
Figure United States Statins Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Statins Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Statins Product Category
Table United States Statins Sales (K Units) by Region (2013-2018)
Table United States Statins Sales Share by Region (2013-2018)
Figure United States Statins Sales Share by Region (2013-2018)
Figure United States Statins Sales Market Share by Region in 2017
Table United States Statins Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Statins Revenue Share by Region (2013-2018)
Figure United States Statins Revenue Market Share by Region (2013-2018)
Figure United States Statins Revenue Market Share by Region in 2017
Table United States Statins Price (USD/Unit) by Region (2013-2018)
Table United States Statins Sales (K Units) by Type (2013-2018)
Table United States Statins Sales Share by Type (2013-2018)
Figure United States Statins Sales Share by Type (2013-2018)
Figure United States Statins Sales Market Share by Type in 2017
Table United States Statins Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Statins Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Statins by Type (2013-2018)
Figure Revenue Market Share of Statins by Type in 2017
Table United States Statins Price (USD/Unit) by Types (2013-2018)
Figure United States Statins Sales Growth Rate by Type (2013-2018)
Table United States Statins Sales (K Units) by Application (2013-2018)
Table United States Statins Sales Market Share by Application (2013-2018)
Figure United States Statins Sales Market Share by Application (2013-2018)
Figure United States Statins Sales Market Share by Application in 2017
Table United States Statins Sales Growth Rate by Application (2013-2018)
Figure United States Statins Sales Growth Rate by Application (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Statins Sales Growth Rate (2013-2018)
Figure Pfizer Statins Sales Market Share in United States (2013-2018)
Figure Pfizer Statins Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Statins Sales Growth Rate (2013-2018)
Figure Merck Statins Sales Market Share in United States (2013-2018)
Figure Merck Statins Revenue Market Share in United States (2013-2018)
Table Teva Basic Information List
Table Teva Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Statins Sales Growth Rate (2013-2018)
Figure Teva Statins Sales Market Share in United States (2013-2018)
Figure Teva Statins Revenue Market Share in United States (2013-2018)
Table Amgen Basic Information List
Table Amgen Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Statins Sales Growth Rate (2013-2018)
Figure Amgen Statins Sales Market Share in United States (2013-2018)
Figure Amgen Statins Revenue Market Share in United States (2013-2018)
Table Abbott Basic Information List
Table Abbott Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Abbott Statins Sales Growth Rate (2013-2018)
Figure Abbott Statins Sales Market Share in United States (2013-2018)
Figure Abbott Statins Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Statins Sales Growth Rate (2013-2018)
Figure AstraZeneca Statins Sales Market Share in United States (2013-2018)
Figure AstraZeneca Statins Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Statins Sales Growth Rate (2013-2018)
Figure Novartis Statins Sales Market Share in United States (2013-2018)
Figure Novartis Statins Revenue Market Share in United States (2013-2018)
Table SUN Pharma Basic Information List
Table SUN Pharma Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure SUN Pharma Statins Sales Growth Rate (2013-2018)
Figure SUN Pharma Statins Sales Market Share in United States (2013-2018)
Figure SUN Pharma Statins Revenue Market Share in United States (2013-2018)
Table Torrent Pharmaceuticals Basic Information List
Table Torrent Pharmaceuticals Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Torrent Pharmaceuticals Statins Sales Growth Rate (2013-2018)
Figure Torrent Pharmaceuticals Statins Sales Market Share in United States (2013-2018)
Figure Torrent Pharmaceuticals Statins Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Statins Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Statins Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline Statins Revenue Market Share in United States (2013-2018)
Table HanAll BioPharma Basic Information List
Table JX Pharmaceuticals Basic Information List
Table Aurobindo Pharma Basic Information List
Table Abbvie Basic Information List
Table Cerenis Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Statins
Figure Manufacturing Process Analysis of Statins
Figure Statins Industrial Chain Analysis
Table Raw Materials Sources of Statins Major Players/Suppliers in 2017
Table Major Buyers of Statins
Table Distributors/Traders List
Figure United States Statins Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Statins Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Statins Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Statins Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Statins Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Statins Sales Volume (K Units) Forecast by Type in 2025
Table United States Statins Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Statins Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Statins Sales Volume (K Units) Forecast by Application in 2025
Table United States Statins Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Statins Sales Volume Share Forecast by Region (2018-2025)
Figure United States Statins Sales Volume Share Forecast by Region (2018-2025)
Figure United States Statins Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT